145 related articles for article (PubMed ID: 36108931)
21. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomic hybridization (CGH) of augmentation cystoplasties.
Appanna TC; Doak SH; Jenkins SA; Kynaston HG; Stephenson TP; Parry JM
Int J Urol; 2007 Jun; 14(6):539-44. PubMed ID: 17593101
[TBL] [Abstract][Full Text] [Related]
23. Bladder carcinoma arising from regenerated urothelium over lyophilized dura patch.
Selli C; Carcangiu ML; Carini M
Urology; 1986 Jan; 27(1):53-5. PubMed ID: 3942022
[TBL] [Abstract][Full Text] [Related]
24. Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review.
Golomb J; Klutke CG; Lewin KJ; Goodwin WE; deKernion JB; Raz S
J Urol; 1989 Aug; 142(2 Pt 1):377-80. PubMed ID: 2545929
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of pembrolizumab in a rare type of bladder cancer arising 25 years after augmentation cystoplasty.
Kitamura K; Isotani S; Muto S; Horie S
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354571
[TBL] [Abstract][Full Text] [Related]
27. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas.
Alexander RE; Lopez-Beltran A; Montironi R; MacLennan GT; Post KM; Bilbo SA; Jones TD; Huang W; Rao Q; Sen JD; Meehan K; Cornwell A; Miravalle L; Cheng L
Histopathology; 2012 Dec; 61(6):1036-42. PubMed ID: 22804747
[TBL] [Abstract][Full Text] [Related]
28. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes of Bladder Neck Reconstruction without Augmentation Cystoplasty in Children.
Grimsby GM; Menon V; Schlomer BJ; Baker LA; Adams R; Gargollo PC; Jacobs MA
J Urol; 2016 Jan; 195(1):155-61. PubMed ID: 26173106
[TBL] [Abstract][Full Text] [Related]
30. [Adenocarcinoma arising in an ileum segment of Scheele's ring 50 years after cystoplasty].
Sugishita K; Mouri G; Nishimura Y; Takeuchi I; Ishizu A; Shinohara N
Nihon Hinyokika Gakkai Zasshi; 2014 Oct; 105(4):207-11. PubMed ID: 25757352
[TBL] [Abstract][Full Text] [Related]
31. Combined method of bladder neck closure and concomitant augmentation cystoplasty in the setting of refractory urinary incontinence.
Blaschko SD; Yang JH; Baskin LS; Deng DY
Urology; 2012 Apr; 79(4):955-7. PubMed ID: 22342417
[TBL] [Abstract][Full Text] [Related]
32. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.
Zhang X; Zhang S; Yang X; Yang J; Zhou Q; Yin L; An S; Lin J; Chen S; Xie Z; Zhu M; Zhang X; Wu YL
Mol Cancer; 2010 Jul; 9():188. PubMed ID: 20624322
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
Necchi A; Madison R; Raggi D; Jacob JM; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Huang R; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Alexander BM; Grivas P; Ross JS
Eur Urol; 2020 Apr; 77(4):548-556. PubMed ID: 31959546
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
[TBL] [Abstract][Full Text] [Related]
35. Thirty-day hospital readmissions after augmentation cystoplasty: A Nationwide readmissions database analysis.
Maldonado N; Michel J; Barnes K
J Pediatr Urol; 2018 Dec; 14(6):533.e1-533.e9. PubMed ID: 30061087
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
[TBL] [Abstract][Full Text] [Related]
37. Ileal neobladder adenocarcinoma occurring twenty-five years post ileocystoplasty: a case report.
Agrawal M; Malvi G; Agrawal N; Narayanaswamy S; Goradia R; Patil B; Patwardhan S
Pan Afr Med J; 2023; 44():149. PubMed ID: 37396696
[TBL] [Abstract][Full Text] [Related]
38. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
39. Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Cheng L; Lopez-Beltran A; Wang M; Montironi R; Kaimakliotis HZ; Zhang S
Mod Pathol; 2021 Jul; 34(7):1384-1391. PubMed ID: 33674765
[TBL] [Abstract][Full Text] [Related]
40. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
